OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II trial of bryostatin-1 in combination with cisplatin in patients with recurrent or persistent epithelial ovarian cancer: a California cancer consortium study

HTML

Year: 2010
Type: article
Study design: Clinical Trial
Source: Investigational New Drugs
DOI: 10.1007/s10637-010-9557-5
Authors: Robert J. Morgan, Lucille Leong, Warren Chow, David Gandara, Paul Frankel, Agustin Garcia, Heinz-Josef Lenz, James H. Doroshow
Institutions: City Of Hope National Medical Center, University of California, Davis, University of Southern California, National Cancer Institute
Language: English

Topic: Ovarian cancer diagnosis and treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: bryostatin 1, cisplatin, epithelial ovarian cancer, recurrent ovarian cancer, platinum-resistant ovarian cancer, PKC inhibitors, combination chemotherapy, continuous infusion, treatment toxicity, myalgia, progression-free survival, overall survival
SDG: Good health and well-being

Open Access status: green

Funders: National Cancer Institute, National Institute of General Medical Sciences
Awards: Modeling and Analysis of Roles of Yeast Sphingolipids, Phase I Molecular and Clincal Pharmacodynamic Trials, G7036783463, PHARMACODYNAMIC PHASE II BREAST, LUNG AND OVARY TRIALS, Cancer Center Support Grant
OpenAlex ID: W2111707367
FWCI: 1.34
Cites: 29
Cited by: 47
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security